On ECHEMI
Home > Drugs > Wuhan Pusheng Pharmaceutical Co., Ltd.
Wuhan Pusheng Pharmaceutical Co., Ltd.
  • Founded in:

    1998-05-11
  • Country:

    China China
  • Address:

    No. 1, Miaoshan Sunshine Avenue, Jiangxia District, Wuhan
  • Tax NO.:

    91420000707090425F
  • Registered Funds:

    23.141141 million yuan
  • Email:

Related Drugs
ATP-Coenzyme Insulin for Injection
This product is a compound preparation, each of which contains 20 mg of adenosine disodium triphosphate, 50 units of coenzyme A, and 4 units of insulin.
Name Description Content CAS NO. Registered Holders
ATP disodium salt

Improves the body's metabolism, participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotides, and is also a source of energy in the body

More

Improves the body's metabolism, participates in the metabolism of fat, protein, sugar, nucleic acid and nucleotides, and is also a source of energy in the body

20mg 987-65-5 8
Coenzyme A

It plays an important role in the metabolism of sugar, fat and protein, and is closely related to the synthesis of acetylcholine, the accumulation of liver glycogen, the reduction of cholesterol and the regulation of blood lipid content.

More

It plays an important role in the metabolism of sugar, fat and protein, and is closely related to the synthesis of acetylcholine, the accumulation of liver glycogen, the reduction of cholesterol and the regulation of blood lipid content.

50unit 85-61-0 4
INSULIN

It can lower blood sugar, inhibit glycogenolysis and glycogenolysis, promote muscle and fat tissue to absorb glucose and amino acids, and promote the decomposition of very low density lipoprotein.

More

It can lower blood sugar, inhibit glycogenolysis and glycogenolysis, promote muscle and fat tissue to absorb glucose and amino acids, and promote the decomposition of very low density lipoprotein.

4unit 11070-73-8 3
Doxofylline for injection
The main ingredient of this product is doxofylline. Its chemical name is 1,3-dimethyl-7-(1,3-dioxolan-2-yl)methyl-3,7-dihydro-1H-purine-2,6-dione. Molecular formula: C11H14N4O4. Molecular weight: 266.26.
Name Description Content CAS NO. Registered Holders
Doxofylline

A derivative of methylxanthine, a bronchodilator, relaxes bronchial smooth muscle by inhibiting phosphodiesterase in smooth muscle cells, thereby suppressing asthma.

More

A derivative of methylxanthine, a bronchodilator, relaxes bronchial smooth muscle by inhibiting phosphodiesterase in smooth muscle cells, thereby suppressing asthma.

69975-86-6 28
Netilmicin Sulfate for Injection
The main ingredient of this product is netilmicin sulfate, whose chemical name is O-3-deoxy C-methyl-3-methylamino-beta;-L-arabinopyranosyl (1rarr;4)-O[2,6-diamino-2,3,4,6-tetradeoxy-alpha;-D-glyceryl-4-enehexopyranosyl-(1rarr;6)]-2-deoxy-N3-ethyl-L-streptamine sulfate.
Name Description Content CAS NO. Registered Holders
Netilmicin sulfate

It works by inhibiting the normal protein synthesis of sensitive microorganisms and has a wide range of antimicrobial effects, mainly targeting Gram-negative rods and a few Gram-positive bacteria, including Citrobacter, Enterobacter, Escherichia coli, Klebsiella, Morgan Proteus, Pseudomonas aeruginosa, Salmonella, Shigella and Staphylococcus (penicillin- and methicillin-resistant). It is also active in vitro against some isolated Acinetobacter, Neisseria, indole-positive Proteus, Pseudomonas, and Serratia. Most streptococci and anaerobic microorganisms such as Clostridium are resistant to aminoglycosides.

More

It works by inhibiting the normal protein synthesis of sensitive microorganisms and has a wide range of antimicrobial effects, mainly targeting Gram-negative rods and a few Gram-positive bacteria, including Citrobacter, Enterobacter, Escherichia coli, Klebsiella, Morgan Proteus, Pseudomonas aeruginosa, Salmonella, Shigella and Staphylococcus (penicillin- and methicillin-resistant). It is also active in vitro against some isolated Acinetobacter, Neisseria, indole-positive Proteus, Pseudomonas, and Serratia. Most streptococci and anaerobic microorganisms such as Clostridium are resistant to aminoglycosides.

56391-57-2 4
Ozagrel Sodium for Injection
Ozagrel sodium.
Name Description Content CAS NO. Registered Holders
Ozagrel sodium

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

More

This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.

189224-26-8 10
Ganciclovir for injection
Ganciclovir. Its chemical name is: 9-(1,3-diopyridine-2-propoxymethyl)-guanine.
Name Description Content CAS NO. Registered Holders
Ganciclovir

Ganciclovir is a guanine antiviral drug. It is a homologue of acyclovir but has a stronger effect. It has a strong inhibitory effect on cytomegalovirus in AIDS patients. After entering the cell, this product is rapidly phosphorylated to form a monophosphate compound, and then converted into a triphosphate compound by the action of cellular kinase. The phosphorylation process in cells infected with cytomegalovirus is faster than that in normal cells. Triphosphates can competitively inhibit DNA polymerase and be incorporated into the DNA of viruses and host cells, thereby inhibiting DNA synthesis. The inhibitory effect on viral DNA polymerase is stronger than that on host cell DNA polymerase.

More

Ganciclovir is a guanine antiviral drug. It is a homologue of acyclovir but has a stronger effect. It has a strong inhibitory effect on cytomegalovirus in AIDS patients. After entering the cell, this product is rapidly phosphorylated to form a monophosphate compound, and then converted into a triphosphate compound by the action of cellular kinase. The phosphorylation process in cells infected with cytomegalovirus is faster than that in normal cells. Triphosphates can competitively inhibit DNA polymerase and be incorporated into the DNA of viruses and host cells, thereby inhibiting DNA synthesis. The inhibitory effect on viral DNA polymerase is stronger than that on host cell DNA polymerase.

82410-32-0 36
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.